Biontech SE
biontech.comWhat Do They Do?
Develops and sells medicines and vaccine products, including cancer immunotherapies and vaccines for infectious diseases, for patients and healthcare markets.
20-F for FY2025, filed Mar 10, 2026We are a global next-generation immunotherapy company aiming to pioneer novel medicines against cancer, infectious diseases and other…View ↗
We have built a broad toolkit across multiple technology platforms, including a diverse range of potentially first- in-class therapeutic…View ↗
In infectious diseases, our goal is to develop vaccines and therapeutics caused by respiratory viruses, latent viruses, bacteria and…View ↗
Our approach has generated a robust and diversified product candidate pipeline across a range of technologies in oncology and infectious…View ↗
How Are They Changing?
Broader in-house capabilities
The latest report describes an integrated model that adds commercial capabilities, computational medicine, data science, and artificial intelligence and machine learning to research, manufacturing, and drug development.
20-F for FY2022, filed Mar 27, 2023 20-F for FY2025, filed Mar 10, 2026Our fully integrated model combines decades of research in immunology, translational drug discovery and development, a technology agnostic…View ↗
We are a global next-generation immunotherapy company aiming to pioneer novel medicines against cancer, infectious diseases and other…View ↗
Different platform mix
The older report lists cell and gene therapies and small molecule immunomodulators among its platforms; the latest report instead names protein-based therapeutics, including targeted antibodies and antibody-drug conjugates.
20-F for FY2022, filed Mar 27, 2023 20-F for FY2025, filed Mar 10, 2026We have built a broad toolkit across multiple technology platforms, including a diverse range of potentially first-in-class therapeutic…View ↗
We have built a broad toolkit across multiple technology platforms, including a diverse range of potentially first- in-class therapeutic…View ↗
Loading...
